Apheresis Market Size to Surge to USD 6.7 Billion by 2034, Driven by Strong Growth Momentum at 7.7% CAGR | Report by Transparency Market Research, Inc. [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
Wilmington, Delaware, United States, Transparency Market Research, Inc. , Aug. 28, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global apheresis market (pasaran apheresis) was worth US$ 2.9 Billion in 2023 and is expected to reach US$ 6.7 Billion by the year 2034 at a CAGR of 7.7 % between 2024 and 2034. Apheresis, also known as pheresis or hemapheresis, is a specialized medical procedure that involves removing whole blood from a donor or patient and separating it into individual components such as red blood cells, white blood cells, platelets, and plasma for therapeutic or diagnostic purposes. This process is facilitated by a centrifuge machine, which draws blood from the patient, separates it into its individual components through spinning, and then isolates the targeted elements. The remaining blood components are subsequently returned to the patient's bloodstream. This technique is widely used in various medical treatments, thereby
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024PR Newswire
- Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.MarketBeat
- Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025 [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) is now covered by analysts at CL King. They set a "buy" rating and a $116.00 price target on the stock.MarketBeat
- Haemonetics Co. (NYSE: HAE) is now covered by analysts at Bank of America Co.. They set a "neutral" rating and a $85.00 price target on the stock.MarketBeat
HAE
Earnings
- 8/9/24 - Miss
HAE
Sec Filings
- 11/5/24 - Form 4
- 9/18/24 - Form 4
- 9/16/24 - Form 8-K
- HAE's page on the SEC website